Contact Address
Prof. Dr. med. Markus Zuber
Tel. +41 62 311 42 30
Fax +41 62 311 41 25
markus.zuber@spital.so.ch

Congress Management
Daniel A. Grosskinsky
c/o Tourismus Biel Seeland
Zentralstrasse 60
Postfach 1261
CH-2501 Biel-Bienne
Tel. +41 32 329 84 86
Fax +41 32 329 84 85
Mob. +41 79 341 41 62
info@cancersurgery.ch

Swiss Course on Cancer Surgery

Biel/Bienne, Thursday - Friday, 18th & 19th April 2013

Publication Downloads

Morbidity of Sentinel Lymph Node Biopsy

Morbidity of Sentinel Lymph Node Biopsy (SLN)
Alone Versus SLN and Completion Axillary Lymph Node
Dissection After Breast Cancer Surgery
A Prospective Swiss Multicenter Study on 659 Patients

Langer I, Guller U, Berclaz G, Ossi R. Koechli, Schaer G,
Fehr M.K, Hess T, Oertli D, Bronz L, Schnarwyler B, Wight E,
Uehlinger U, Infanger E, Burger D, Zuber M

> Ann Surg 2007;245:252-461 (PDF 440 KB)

Bone Marrow Micrometastases and Sentiel Lymph Node Status

Association of the Presence of Bone Marrow Micrometastases
with the Sentinel Lymph Node Status in 410 Early Stage
Breast Cancer Patients: Results of the Swiss Multicenter Study

Langer I, Guller U, Ossi R. Koechli, Berclaz G, Singer G, Schaer G,
Fehr M.K, Hess T, Oertli D, Bronz L, Schnarwyler B, Wight E, 
Uehlinger U, Infanger E, Burger D, Zuber M
for the Swiss Multicenter Sentinel Lymph Node Study Group in Breast Cancer

> Ann Surg 2007;14:1896-1903 (PDF 231 KB)

Axillary Recurrence Rate and Sentinel Micrometastases

Axillary Recurrence Rate in Breast Cancer Patients With
Negative Sentinel Lymph Node (SLN) or SLN Micrometastases
Prospective Analysis of 150 Patients After SLN Biopsy

Langer I, Marti W.R, Guller U, Moch H, Harder F, Oertli D, Zuber M

> Ann Surg 2005;241:152-158 (PDF 268 KB)

PET: not yet

Is Positron Emission Tomography an Accurate
Non-invasive Alternative to Sentinel Lymph Node Biopsy
in Breast Cancer Patients?

Guller U, Nitzsche E, Moch H, Zuber M

> J Nat Cancer Inst 2003;95:1040-1043 (PDF 55 KB)

Improved Survival due to Sentinel Biopsy

Sentinel lymph node biopsy is associated with improved survival compared to level
I & II axillary lymph node dissection in node negative breast cancer patients

Langer I, Guller U, Hsu-Schmitz F, Ladewig A, Viehl CT, Moch H, Wight E, Harder F, Oertli D, Zuber M

> Eur J Srg Oncol 2008;doi:10.1016/j.ejso.2008.09.006 (PDF 298 KB)

Frozen section of sentinel lymph nodes

Accuracy of frozen section of sentinel lymph nodes:
a prospective analysis of 659 breast cancer patients
of the Swiss multicenter study

Langer I, Guller U, Berclaz G, Koechli O.R, Moch H, Schaer G, 
Fehr M.K, Hess T, Oertli D, Bronz L, Schnarwyler B, 
Wight E, Uehlinger U, Infanger E, Burger D, Zuber M
For the Swiss Multicenter Study Group Sentinel Lymph Node in Breast Cancer

> Breast Cancer Res Treat 2009;113:129-136 (PDF 208 KB)

Nachsorge Mammakarzinom

Nachsorge-Empfehlungen für Patientinnen mit
kurativ therapiertem, invasivem Mammakarzinom

Zuber M, Viehl C.T, Güller U, Langer I

> Ther Umschau 2008;65:319-321 (PDF 504 KB)

Identification of Sentinel Lymph Nodes in Colon Cancer

Identification of Sentinel Lymph Nodes in Colon Cancer Depends
on the Amount of Dye Injected Relative to Tumor Size

Viehl C.T, Hamel C.T, Marti W.R, Guller U, Eisner L,
Stammberger U, Terracciano L, Spichtin H.P, Harder F, Zuber M

> World J Surg 2003;27:1285-1290 (PDF 129 KB)

Carbon Dye Staining of Sentinel Lymph Nodes in Colon Cancer

Carbon Dye Staining of Sentinel Lymph Nodes
Facilitates Microstaging of Colon Cancer Patients

Viehl C.T, Guller U, Hamel C.T, Riehle H-M, Plaass C, Marti W.R, Oertli D, Zuber M

> World J Surg 2006; 30:1-4 (PDF 237 KB)

Immunotherapy Trials for Malignant Melanoma

Active Specific Immunotherapy Phase III Trials for
Malignant Melanoma: Systematic Analysis and
Critical Appraisal

Rosenthal R, Viehl C.T, Guller U, Weber W.P, Adamina M, Spagnoli G.C, Heberer M, Zuber M

> J Am Col Surg;2008:207:95-105 (PDF 158 KB)

Nachsorgeschema kolorektalem Karzinom

Revidierte Konsensus-Empfehlungen zur Nachsorge
nach koloskopischer Polypektomie
und nach kurativ operiertem kolorektalem Karzinom

Dominique Criblez
Für den Vorstand der Schweizerischen Gesellschaft für Gastroenterologie (SGG/SSG)

> Schweiz Med Forum 2007;7:994-999 (PDF 210 KB)

Interdiciplinary Tumor Boards

Interdisciplinary tumour boards in Switzerland: quo vadis?
Lehmann K, Güller U, Bugnon S, Zuber M 

> Swiss Medical Weekly 2008;138:123-127 (PDF 265 KB)

Bildergalerie 2013

Hier finden Sie unsere
Bildergalerie des SCCS 2013.

Sponsored by